questionsmedicales.fr
Enzymes et coenzymes
Enzymes
Oxidoreductases
NADH, NADPH oxidoreductases
NADH, NADPH oxidoreductases : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Déficience enzymatique
Tests génétiques
Fatigue
Troubles métaboliques
Activité enzymatique
Évaluation fonctionnelle
Anomalies génétiques
Mutations
Symptômes
5
Déficience en NADPH
Infections fréquentes
Troubles neurologiques
Dysfonctionnement enzymatique
Troubles digestifs
Métabolisme énergétique
Prévention
5
Alimentation équilibrée
Nutriments essentiels
Mode de vie sain
Exercice
Bilans de santé
Anomalies enzymatiques
Éducation nutritionnelle
Carences
Traitements
5
Suppléments enzymatiques
Modifications diététiques
Thérapie génique
Déficiences enzymatiques
Médicaments
Modulation enzymatique
Transfusions sanguines
Déficiences
Complications
5
Complications
Troubles métaboliques
Infections
Déficiences enzymatiques
Maladies chroniques
Diabète
Complications cardiovasculaires
Troubles métaboliques
Complications hématologiques
Métabolisme
Facteurs de risque
5
Antécédents familiaux
Maladies métaboliques
Mode de vie sédentaire
Mauvaise alimentation
Maladies génétiques
Prédisposition
Stress oxydatif
Déficiences enzymatiques
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "NADH, NADPH oxidoreductases : Questions médicales les plus fréquentes",
"headline": "NADH, NADPH oxidoreductases : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les NADH, NADPH oxidoreductases : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-05",
"dateModified": "2025-04-01",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "NADH, NADPH oxidoreductases"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Oxidoreductases",
"url": "https://questionsmedicales.fr/mesh/D010088",
"about": {
"@type": "MedicalCondition",
"name": "Oxidoreductases",
"code": {
"@type": "MedicalCode",
"code": "D010088",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Cytochrome reductases",
"alternateName": "Cytochrome Reductases",
"url": "https://questionsmedicales.fr/mesh/D003579",
"about": {
"@type": "MedicalCondition",
"name": "Cytochrome reductases",
"code": {
"@type": "MedicalCode",
"code": "D003579",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.608.191"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "NADPH-ferrihemoprotéine reductase",
"alternateName": "NADPH-Ferrihemoprotein Reductase",
"url": "https://questionsmedicales.fr/mesh/D009251",
"about": {
"@type": "MedicalCondition",
"name": "NADPH-ferrihemoprotéine reductase",
"code": {
"@type": "MedicalCode",
"code": "D009251",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.608.191.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "NADH tetrazolium reductase",
"alternateName": "NADH Tetrazolium Reductase",
"url": "https://questionsmedicales.fr/mesh/D009246",
"about": {
"@type": "MedicalCondition",
"name": "NADH tetrazolium reductase",
"code": {
"@type": "MedicalCode",
"code": "D009246",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.608.530"
}
}
},
{
"@type": "MedicalWebPage",
"name": "NADP transhydrogenases",
"alternateName": "NADP Transhydrogenases",
"url": "https://questionsmedicales.fr/mesh/D009250",
"about": {
"@type": "MedicalCondition",
"name": "NADP transhydrogenases",
"code": {
"@type": "MedicalCode",
"code": "D009250",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.608.540"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "NADP transhydrogenase, AB-specific",
"alternateName": "NADP Transhydrogenase, AB-Specific",
"url": "https://questionsmedicales.fr/mesh/D061087",
"about": {
"@type": "MedicalCondition",
"name": "NADP transhydrogenase, AB-specific",
"code": {
"@type": "MedicalCode",
"code": "D061087",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.608.540.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "NADPH dehydrogenase",
"alternateName": "NADPH Dehydrogenase",
"url": "https://questionsmedicales.fr/mesh/D009252",
"about": {
"@type": "MedicalCondition",
"name": "NADPH dehydrogenase",
"code": {
"@type": "MedicalCode",
"code": "D009252",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.608.550"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Quinone reductases",
"alternateName": "Quinone Reductases",
"url": "https://questionsmedicales.fr/mesh/D011808",
"about": {
"@type": "MedicalCondition",
"name": "Quinone reductases",
"code": {
"@type": "MedicalCode",
"code": "D011808",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.608.800"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "NADPH dehydrogenase (quinone)",
"alternateName": "NAD(P)H Dehydrogenase (Quinone)",
"url": "https://questionsmedicales.fr/mesh/D016660",
"about": {
"@type": "MedicalCondition",
"name": "NADPH dehydrogenase (quinone)",
"code": {
"@type": "MedicalCode",
"code": "D016660",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.608.800.500"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "NADH, NADPH oxidoreductases",
"alternateName": "NADH, NADPH Oxidoreductases",
"code": {
"@type": "MedicalCode",
"code": "D009247",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Fei-Long Li",
"url": "https://questionsmedicales.fr/author/Fei-Long%20Li",
"affiliation": {
"@type": "Organization",
"name": "School of Pharmacy, United Pharmaceutical Institute of Jiangsu University and Shandong Tianzhilvye Biotechnology Co. Ltd., Jiangsu University, Zhenjiang 212013, People's Republic of China."
}
},
{
"@type": "Person",
"name": "Ye-Wang Zhang",
"url": "https://questionsmedicales.fr/author/Ye-Wang%20Zhang",
"affiliation": {
"@type": "Organization",
"name": "School of Pharmacy, United Pharmaceutical Institute of Jiangsu University and Shandong Tianzhilvye Biotechnology Co. Ltd., Jiangsu University, Zhenjiang 212013, People's Republic of China; College of Petroleum and Chemical Engineering, Beibu Gulf University, Qinzhou 535011, People's Republic of China. Electronic address: zhangyewang@ujs.edu.cn."
}
},
{
"@type": "Person",
"name": "Chuanwu Xia",
"url": "https://questionsmedicales.fr/author/Chuanwu%20Xia",
"affiliation": {
"@type": "Organization",
"name": "Department of Biochemistry, Medical College of Wisconsin, Milwaukee, WI, 53226, USA."
}
},
{
"@type": "Person",
"name": "Anna L Shen",
"url": "https://questionsmedicales.fr/author/Anna%20L%20Shen",
"affiliation": {
"@type": "Organization",
"name": "McArdle Laboratory for Cancer Research, Department of Oncology, University of Wisconsin School of Medicine and Public Health, Madison, WI, 53706, USA."
}
},
{
"@type": "Person",
"name": "Jung-Ja P Kim",
"url": "https://questionsmedicales.fr/author/Jung-Ja%20P%20Kim",
"affiliation": {
"@type": "Organization",
"name": "Department of Biochemistry, Medical College of Wisconsin, Milwaukee, WI, 53226, USA. Electronic address: jjkim@mcw.edu."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Warning Signs on Short Hammersmith Neonatal Neurological Examination and Correlation With Hammersmith Infant Neurological Examination Global Score in Preterm Infants: A Prospective Cohort Study.",
"datePublished": "2023-03-20",
"url": "https://questionsmedicales.fr/article/37211888",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": null
}
},
{
"@type": "ScholarlyArticle",
"name": "Towards a Comprehensive Solution for a Vision-Based Digitized Neurological Examination.",
"datePublished": "2022-08-11",
"url": "https://questionsmedicales.fr/article/35439148",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1109/JBHI.2022.3167927"
}
},
{
"@type": "ScholarlyArticle",
"name": "Performance of Large Language Models on a Neurology Board-Style Examination.",
"datePublished": "2023-12-01",
"url": "https://questionsmedicales.fr/article/38060223",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1001/jamanetworkopen.2023.46721"
}
},
{
"@type": "ScholarlyArticle",
"name": "Neurological Examination via Telemedicine: An Updated Review Focusing on Movement Disorders.",
"datePublished": "2024-06-09",
"url": "https://questionsmedicales.fr/article/38929575",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/medicina60060958"
}
},
{
"@type": "ScholarlyArticle",
"name": "Pattern and implications of neurological examination findings in autosomal dominant Alzheimer disease.",
"datePublished": "2022-05-24",
"url": "https://questionsmedicales.fr/article/35609137",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/alz.12684"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Enzymes et coenzymes",
"item": "https://questionsmedicales.fr/mesh/D045762"
},
{
"@type": "ListItem",
"position": 3,
"name": "Enzymes",
"item": "https://questionsmedicales.fr/mesh/D004798"
},
{
"@type": "ListItem",
"position": 4,
"name": "Oxidoreductases",
"item": "https://questionsmedicales.fr/mesh/D010088"
},
{
"@type": "ListItem",
"position": 5,
"name": "NADH, NADPH oxidoreductases",
"item": "https://questionsmedicales.fr/mesh/D009247"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : NADH, NADPH oxidoreductases - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur NADH, NADPH oxidoreductases",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-03",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur NADH, NADPH oxidoreductases",
"description": "Comment diagnostiquer une déficience en NADH oxydoréductases ?\nQuels tests sanguins sont utiles pour évaluer NADPH ?\nQuels symptômes indiquent un problème avec ces enzymes ?\nLes tests d'activité enzymatique sont-ils fiables ?\nPeut-on détecter des anomalies génétiques liées à ces enzymes ?",
"url": "https://questionsmedicales.fr/mesh/D009247?mesh_terms=Neurologic+Examination#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur NADH, NADPH oxidoreductases",
"description": "Quels sont les symptômes d'une carence en NADH ?\nComment se manifeste une déficience en NADPH ?\nY a-t-il des symptômes neurologiques associés ?\nLes symptômes varient-ils selon l'âge ?\nDes symptômes digestifs peuvent-ils apparaître ?",
"url": "https://questionsmedicales.fr/mesh/D009247?mesh_terms=Neurologic+Examination#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur NADH, NADPH oxidoreductases",
"description": "Comment prévenir les déficiences en NADH ?\nY a-t-il des habitudes de vie à adopter ?\nLes bilans de santé réguliers sont-ils utiles ?\nLes vaccinations peuvent-elles jouer un rôle ?\nL'éducation nutritionnelle est-elle importante ?",
"url": "https://questionsmedicales.fr/mesh/D009247?mesh_terms=Neurologic+Examination#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur NADH, NADPH oxidoreductases",
"description": "Quels traitements existent pour les déficiences enzymatiques ?\nLa thérapie génique est-elle une option ?\nLes médicaments peuvent-ils aider à réguler ces enzymes ?\nY a-t-il des traitements naturels recommandés ?\nLes transfusions sanguines sont-elles nécessaires ?",
"url": "https://questionsmedicales.fr/mesh/D009247?mesh_terms=Neurologic+Examination#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur NADH, NADPH oxidoreductases",
"description": "Quelles complications peuvent survenir avec une déficience en NADH ?\nLes infections sont-elles une complication fréquente ?\nY a-t-il des risques de maladies chroniques ?\nLes complications cardiovasculaires sont-elles possibles ?\nDes complications hématologiques peuvent-elles survenir ?",
"url": "https://questionsmedicales.fr/mesh/D009247?mesh_terms=Neurologic+Examination#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur NADH, NADPH oxidoreductases",
"description": "Quels facteurs de risque sont associés aux déficiences enzymatiques ?\nL'âge est-il un facteur de risque ?\nLe mode de vie influence-t-il le risque ?\nLes maladies génétiques sont-elles un facteur ?\nLe stress oxydatif joue-t-il un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D009247?mesh_terms=Neurologic+Examination#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une déficience en NADH oxydoréductases ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests enzymatiques et des analyses génétiques peuvent être utilisés pour diagnostiquer."
}
},
{
"@type": "Question",
"name": "Quels tests sanguins sont utiles pour évaluer NADPH ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les dosages de NADPH et d'autres coenzymes dans le sang peuvent être effectués."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un problème avec ces enzymes ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fatigue, faiblesse musculaire et troubles métaboliques peuvent indiquer un problème."
}
},
{
"@type": "Question",
"name": "Les tests d'activité enzymatique sont-ils fiables ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils sont souvent utilisés pour évaluer la fonction des NADH et NADPH oxydoréductases."
}
},
{
"@type": "Question",
"name": "Peut-on détecter des anomalies génétiques liées à ces enzymes ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests génétiques peuvent identifier des mutations affectant ces enzymes."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une carence en NADH ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, troubles cognitifs et faiblesse musculaire."
}
},
{
"@type": "Question",
"name": "Comment se manifeste une déficience en NADPH ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut se manifester par des infections fréquentes et des troubles métaboliques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles neurologiques peuvent survenir en cas de dysfonctionnement enzymatique."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction de l'âge et de l'état de santé général."
}
},
{
"@type": "Question",
"name": "Des symptômes digestifs peuvent-ils apparaître ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles digestifs peuvent être liés à des anomalies dans le métabolisme énergétique."
}
},
{
"@type": "Question",
"name": "Comment prévenir les déficiences en NADH ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée riche en nutriments essentiels peut aider à prévenir ces déficiences."
}
},
{
"@type": "Question",
"name": "Y a-t-il des habitudes de vie à adopter ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sain incluant exercice et gestion du stress est recommandé."
}
},
{
"@type": "Question",
"name": "Les bilans de santé réguliers sont-ils utiles ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des bilans réguliers peuvent aider à détecter précocement des anomalies enzymatiques."
}
},
{
"@type": "Question",
"name": "Les vaccinations peuvent-elles jouer un rôle ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines vaccinations peuvent prévenir des infections qui aggravent les déficiences."
}
},
{
"@type": "Question",
"name": "L'éducation nutritionnelle est-elle importante ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, comprendre l'importance des nutriments peut aider à prévenir les carences."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour les déficiences enzymatiques ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements peuvent inclure des suppléments enzymatiques et des modifications diététiques."
}
},
{
"@type": "Question",
"name": "La thérapie génique est-elle une option ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la thérapie génique est explorée pour traiter certaines déficiences enzymatiques."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils aider à réguler ces enzymes ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains médicaments peuvent aider à moduler l'activité des NADH et NADPH oxydoréductases."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements naturels recommandés ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antioxydants et des nutriments peuvent soutenir la fonction enzymatique."
}
},
{
"@type": "Question",
"name": "Les transfusions sanguines sont-elles nécessaires ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans certains cas graves, des transfusions peuvent être nécessaires pour corriger des déficiences."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec une déficience en NADH ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des troubles métaboliques graves et des problèmes neurologiques."
}
},
{
"@type": "Question",
"name": "Les infections sont-elles une complication fréquente ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes avec des déficiences enzymatiques sont plus susceptibles aux infections."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de maladies chroniques ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des déficiences peuvent augmenter le risque de maladies chroniques comme le diabète."
}
},
{
"@type": "Question",
"name": "Les complications cardiovasculaires sont-elles possibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles métaboliques peuvent entraîner des complications cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Des complications hématologiques peuvent-elles survenir ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies dans le métabolisme peuvent entraîner des complications hématologiques."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque sont associés aux déficiences enzymatiques ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des maladies métaboliques et une mauvaise nutrition."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines déficiences peuvent être plus fréquentes chez les personnes âgées."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et une mauvaise alimentation augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les maladies génétiques sont-elles un facteur ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies génétiques prédisposent aux déficiences en NADH et NADPH."
}
},
{
"@type": "Question",
"name": "Le stress oxydatif joue-t-il un rôle ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress oxydatif peut aggraver les déficiences enzymatiques et leurs effets."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
2 publications dans cette catégorie
Affiliations :
Publications dans "NADH, NADPH oxidoreductases" :
2 publications dans cette catégorie
Affiliations :
Publications dans "NADH, NADPH oxidoreductases" :
2 publications dans cette catégorie
Affiliations :
Publications dans "NADH, NADPH oxidoreductases" :
2 publications dans cette catégorie
Affiliations :
Publications dans "NADH, NADPH oxidoreductases" :
2 publications dans cette catégorie
Affiliations :
Publications dans "NADH, NADPH oxidoreductases" :
2 publications dans cette catégorie
Affiliations :
Publications dans "NADH, NADPH oxidoreductases" :
2 publications dans cette catégorie
Affiliations :
Publications dans "NADH, NADPH oxidoreductases" :
2 publications dans cette catégorie
Affiliations :
Publications dans "NADH, NADPH oxidoreductases" :
2 publications dans cette catégorie
Affiliations :
Publications dans "NADH, NADPH oxidoreductases" :
2 publications dans cette catégorie
Affiliations :
Publications dans "NADH, NADPH oxidoreductases" :
2 publications dans cette catégorie
Affiliations :
Publications dans "NADH, NADPH oxidoreductases" :
1 publication dans cette catégorie
Affiliations :
Publications dans "NADH, NADPH oxidoreductases" :
1 publication dans cette catégorie
Affiliations :
Publications dans "NADH, NADPH oxidoreductases" :
1 publication dans cette catégorie
Affiliations :
Publications dans "NADH, NADPH oxidoreductases" :
1 publication dans cette catégorie
Affiliations :
Publications dans "NADH, NADPH oxidoreductases" :
1 publication dans cette catégorie
Affiliations :
Publications dans "NADH, NADPH oxidoreductases" :
1 publication dans cette catégorie
Affiliations :
Publications dans "NADH, NADPH oxidoreductases" :
1 publication dans cette catégorie
Affiliations :
Publications dans "NADH, NADPH oxidoreductases" :
1 publication dans cette catégorie
Affiliations :
Publications dans "NADH, NADPH oxidoreductases" :
1 publication dans cette catégorie
Affiliations :
Publications dans "NADH, NADPH oxidoreductases" :
To describe the findings of short Hammersmith Neonatal Neurologic examination (HNNE) in preterm small for gestational age (SGA) and appropriate for gestational age (AGA) infants at term equivalent age...
This prospective cohort study was conducted at the high risk follow-up clinic of our center. 52 preterm infants born <35 weeks gestation were examined using HNNE at TEA and followed- up till 4-6 month...
20 infants (38.5%) had warning signs and 9 (17.3%) had abnormal signs on short HNNE. 12 (37.5%) AGA infants and 6 (30%) SGA infants had global score <65 at mean corrected age (SD) of 4.3 (0.7) weeks a...
Early identification of warning signs among SGA infants using Short HNNE screening at TEA can be useful to initiate early intervention. There was no statistically significant difference in global scor...
The ability to use digitally recorded and quantified neurological exam information is important to help healthcare systems deliver better care, in-person and via telehealth, as they compensate for a g...
Recent advancements in large language models (LLMs) have shown potential in a wide array of applications, including health care. While LLMs showed heterogeneous results across specialized medical boar...
To assess the performance of LLMs on neurology board-style examinations....
This cross-sectional study was conducted between May 17 and May 31, 2023. The evaluation utilized a question bank approved by the American Board of Psychiatry and Neurology and was validated with a sm...
Overall percentage scores of 2 LLMs....
LLM 2 significantly outperformed LLM 1 by correctly answering 1662 of 1956 questions (85.0%) vs 1306 questions (66.8%) for LLM 1. Notably, LLM 2's performance was greater than the mean human score of ...
Despite the absence of neurology-specific training, LLM 2 demonstrated commendable performance, whereas LLM 1 performed slightly below the human average. While higher-order cognitive tasks were more c...
Patients with movement disorders such as Parkinson's disease (PD) living in remote and underserved areas often have limited access to specialized healthcare, while the feasibility and reliability of t...
As knowledge about neurological examination findings in autosomal dominant Alzheimer disease (ADAD) is incomplete, we aimed to determine the frequency and significance of neurological examination find...
Frequencies of neurological examination findings were compared between symptomatic mutation carriers and non mutation carriers from the Dominantly Inherited Alzheimer Network (DIAN) to define AD neuro...
AD neurological examination findings included abnormal deep tendon reflexes, gait disturbance, pathological cranial nerve examination findings, tremor, abnormal finger to nose and heel to shin testing...
ADAD features a distinct pattern of neurological examination findings that is useful to estimate prognosis and may inform clinical care and therapeutic trial designs....
The neurological examination of an unwell neonate can aid management, such as deciding if hypothermia treatment is warranted in hypoxic ischaemic encephalopathy or directing investigations in hypotoni...
An explanatory sequential mixed methods approach (QUAN → QUAL) with equal weighting between stages. A survey on attitudes to the neonatal neurological examination was sent to all UK neonatal units and...
One hundred ninety-three surveys were returned, 31.0% from neonatologists, 9.3% paediatric neurologist. The median range for confidence was 4 (IQR3-5). Twenty-three interviews occurred. Thematic analy...
There are barriers preventing paediatricians being able to perform a neurological examination in unwell neonates, and a culture of neurophobia is common. A new standardised examination is needed, alon...
Frequent neurological examinations in patients with traumatic brain injury (TBI) disrupt sleep-wake cycles and potentially contribute to the development of delirium....
To evaluate the risk of delirium among patients with TBI with respect to their neuro-check frequencies....
A retrospective study of patients presenting with TBI at a single level I trauma center between January 2018 and December 2019. The primary exposure was the frequency of neurological examinations (neu...
Of 1552 patients with TBI, 458 (29.5%) patients experienced delirium during their hospital stay. The median time-to-delirium was 1.8 days (IQR: 1.1, 2.9). Kaplan-Meier analysis demonstrated that patie...
Patients with more frequent neuro-checks had a higher risk of developing delirium compared with those with less frequent neuro-checks....
The Hammersmith infant neurological examination (HINE) is a highly predictive tool for the easy and low-cost detection of cerebral palsy. Between 2015 and 2016, the rapid spread of the Zika virus (ZIK...
Bulbar symptoms in amyotrophic lateral sclerosis (ALS) are variable, reflecting bulbar and pseudobulbar palsy. The current study sought to characterize the pharyngeal findings in ALS using a fiberopti...
We enrolled ALS patients with bulbar symptoms who were admitted between 2014 and 2020. All participants were evaluated on salivary status, velopharyngeal movement during speech and swallowing, pharyng...
A total of 50 patients (31 men; median age: 69 years) were enrolled. Salivary residue in the hypopharynx was the most common abnormal finding on laryngoscopy (40 patients; 80%). Twenty-three patients ...
The specific findings of laryngoscopy in ALS patients, such as SSD in velopharyngeal closure and laterality in pharyngeal constriction, could not be evaluated by general neurological examination via t...
Traumatic brain injury (TBI) management includes serial neurologic examinations to assess for changes dictating neurosurgical interventions. We hypothesized hourly examinations are overassigned. We co...
A retrospective cohort study of 1022 patients with TBI admitted to a Level 1 trauma center from January 1, 2019, to December 31, 2019, was conducted. Patients with penetrating TBI or immediate or plan...
A total of 830 patients were included, 287 (35%) were assigned hourly (Q1) examinations, and 17 (2%) had unplanned procedures, with 16 of 17 (94%) on Q1 examinations. Patients requiring unplanned proc...
Using a 4-factor algorithm can optimize the assignment of neuro examinations and substantially reduce neuro examination burden without sacrificing patient safety....
